Alnylam Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ALNY for the last quarter is 494.33 M USD, and it's 12.42% higher compared to the previous quarter. The net income of Q1 24 is -65.94 M USD.